Philadelphia chromosome-positive chronic myelogenous leukemia in treated Hodgkin's disease
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 49 (2) , 171-176
- https://doi.org/10.1016/0165-4608(90)90139-2
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients [see comments]Blood, 1988
- Solid cancer risk after treatment of Hodgkin's diseaseCancer, 1988
- Risk of Second Cancers after Treatment for Hodgkin's DiseaseNew England Journal of Medicine, 1988
- Decreasing Risk of Leukemia with Prolonged Follow-up after Chemotherapy and Radiotherapy for Hodgkin's DiseaseNew England Journal of Medicine, 1987
- Altered Transcription of the c- abl Oncogene in K-562 and Other Chronic Myelogenous Leukemia CellsScience, 1984
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1984
- Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22Cell, 1984
- Occurrence of Non-Hodgkin's Lymphoma after Therapy for Hodgkin's DiseaseNew England Journal of Medicine, 1979
- A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa StainingNature, 1973
- Chronic myelogenous leukemia in Hodgkin's disease: Immunofluorescence of cellsCancer, 1971